Researchers at Washington University School of Medicine in St. Louis have received a $12 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.
$12 million grant aimed at probing how vaccines induce lasting immunity
View Content